A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China's reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Biosimilars industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Other
Market Segment by Product Application
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
Finally, the report provides detailed profile and data information analysis of leading company.
- Roche
- Eli Lilly
- Sanofi-Aventis
- Amgen
- Novo Nordisk
- AbbVie
- Merck
- Pfizer
- Johnson & Johnson
- Novartis
- Gelgen
- Ganlee
- 3sbio
- Innovent
- Biotech
- Changchun High Tech
- Dong Bao
- CP Guojian
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
- 1.To study and analyze the global Biosimilars consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
- 2.To understand the structure of Biosimilars market by identifying its various subsegments.
- 3.Focuses on the key global Biosimilars manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- 4.To analyze the Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
- 5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- 6.To project the consumption of Biosimilars submarkets, with respect to key regions (along with their respective key countries).
- 7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- 8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Table of Contents
Global Biosimilars Professional Survey Report Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilars Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilars Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Erythropoietin
2.1.4 Insulin
2.1.5 Vaccines
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Tumor
2.2.2 Diabetes
2.2.3 Cardiovascular
2.2.4 Hemophilia
2.2.5 Other
2.3 Global Biosimilars Market Comparison by Regions (2018-2028)
2.3.1 Global Biosimilars Market Size (2018-2028)
2.3.2 North America Biosimilars Status and Prospect (2018-2028)
2.3.3 Europe Biosimilars Status and Prospect (2018-2028)
2.3.4 Asia-pacific Biosimilars Status and Prospect (2018-2028)
2.3.5 South America Biosimilars Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Biosimilars Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Biosimilars Industry Impact
2.5.1 Biosimilars Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilars Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Biosimilars Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Biosimilars Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilars Manufacturer Market Share
3.5 Top 10 Biosimilars Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilars Market
3.7 Key Manufacturers Biosimilars Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilars Industry Key Manufacturers
4.1 Roche
4.1.1 Company Details
4.1.2 Roche Biosimilars Product Introduction, Application and Specification
4.1.3 Roche Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Eli Lilly
4.2.1 Company Details
4.2.2 Eli Lilly Biosimilars Product Introduction, Application and Specification
4.2.3 Eli Lilly Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Eli Lilly News
4.3 Sanofi-Aventis
4.3.1 Company Details
4.3.2 Sanofi-Aventis Biosimilars Product Introduction, Application and Specification
4.3.3 Sanofi-Aventis Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Sanofi-Aventis News
4.4 Amgen
4.4.1 Company Details
4.4.2 Amgen Biosimilars Product Introduction, Application and Specification
4.4.3 Amgen Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Amgen News
4.5 Novo Nordisk
4.5.1 Company Details
4.5.2 Novo Nordisk Biosimilars Product Introduction, Application and Specification
4.5.3 Novo Nordisk Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Novo Nordisk News
4.6 AbbVie
4.6.1 Company Details
4.6.2 AbbVie Biosimilars Product Introduction, Application and Specification
4.6.3 AbbVie Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 AbbVie News
4.7 Merck
4.7.1 Company Details
4.7.2 Merck Biosimilars Product Introduction, Application and Specification
4.7.3 Merck Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.5 Merck News
4.8 Pfizer
4.8.1 Company Details
4.8.2 Pfizer Biosimilars Product Introduction, Application and Specification
4.8.3 Pfizer Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Johnson & Johnson
4.9.1 Company Details
4.9.2 Johnson & Johnson Biosimilars Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 Novartis
4.10.1 Company Details
4.10.2 Novartis Biosimilars Product Introduction, Application and Specification
4.10.3 Novartis Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Gelgen
4.11.1 Company Details
4.11.2 Gelgen Biosimilars Product Introduction, Application and Specification
4.11.3 Gelgen Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.11.4 Main Business Overview
4.11.5 Gelgen News
4.12 Ganlee
4.12.1 Company Details
4.12.2 Ganlee Biosimilars Product Introduction, Application and Specification
4.12.3 Ganlee Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.12.4 Main Business Overview
4.12.5 Ganlee News
4.13 3sbio
4.13.1 Company Details
4.13.2 3sbio Biosimilars Product Introduction, Application and Specification
4.13.3 3sbio Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.13.4 Main Business Overview
4.13.5 3sbio News
4.14 Innovent
4.14.1 Company Details
4.14.2 Innovent Biosimilars Product Introduction, Application and Specification
4.14.3 Innovent Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.14.4 Main Business Overview
4.14.5 Innovent News
4.15 Biotech
4.15.1 Company Details
4.15.2 Biotech Biosimilars Product Introduction, Application and Specification
4.15.3 Biotech Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.15.4 Main Business Overview
4.15.5 Biotech News
4.16 Changchun High Tech
4.16.1 Company Details
4.16.2 Changchun High Tech Biosimilars Product Introduction, Application and Specification
4.16.3 Changchun High Tech Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.16.4 Main Business Overview
4.16.5 Changchun High Tech News
4.17 Dong Bao
4.17.1 Company Details
4.17.2 Dong Bao Biosimilars Product Introduction, Application and Specification
4.17.3 Dong Bao Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.17.4 Main Business Overview
4.17.5 Dong Bao News
4.18 CP Guojian
4.18.1 Company Details
4.18.2 CP Guojian Biosimilars Product Introduction, Application and Specification
4.18.3 CP Guojian Biosimilars Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.18.4 Main Business Overview
4.18.5 CP Guojian News
5 Global Biosimilars Sales Categorized by Regions
5.1 Global Biosimilars Revenue, Sales and Market Share by Regions
5.1.1 Global Biosimilars Sales and Market Share by Regions (2018-2023)
5.1.2 Global Biosimilars Revenue and Market Share by Regions (2018-2023)
5.2 North America Biosimilars Sales and Growth Rate (2018-2023)
5.3 Europe Biosimilars Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Biosimilars Sales and Growth Rate (2018-2023)
5.5 South America Biosimilars Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Biosimilars Sales and Growth Rate (2018-2023)
6 North America Biosimilars Market Size Categorized by Countries
6.1 North America Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 North America Biosimilars Sales (Volume) by Countries (2018-2023)
6.1.2 North America Biosimilars Revenue by Countries (2018-2023)
6.1.3 United States Biosimilars Sales and Growth Rate (2018-2023)
6.1.4 Canada Biosimilars Sales and Growth Rate (2018-2023)
6.1.5 Mexico Biosimilars Sales and Growth Rate (2018-2023)
6.2 North America Biosimilars Revenue (Value) by Manufacturers
6.3 North America Biosimilars Sales and Market Share by Type (2018-2023)
6.4 North America Biosimilars Sales Market Share by Application (2018-2023)
7 Europe Biosimilars Market Size Categorized by Countries
7.1 Europe Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Europe Biosimilars Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Biosimilars Revenue by Countries (2018-2023)
7.1.3 Germany Biosimilars Sales and Growth Rate (2018-2023)
7.1.4 UK Biosimilars Sales and Growth Rate (2018-2023)
7.1.5 France Biosimilars Sales and Growth Rate (2018-2023)
7.1.6 Russia Biosimilars Sales and Growth Rate (2018-2023)
7.1.7 Italy Biosimilars Sales and Growth Rate (2018-2023)
7.1.8 Spain Biosimilars Sales and Growth Rate (2018-2023)
7.2 Europe Biosimilars Revenue (Value) by Manufacturers
7.3 Europe Biosimilars Sales and Market Share by Type (2018-2023)
7.4 Europe Biosimilars Sales Market Share by Application (2018-2023)
8 Asia-Pacific Biosimilars Market Size Categorized by Countries
8.1 Asia-pacific Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Biosimilars Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Biosimilars Revenue by Countries (2018-2023)
8.1.3 China Biosimilars Sales and Growth Rate (2018-2023)
8.1.4 South Korea Biosimilars Sales and Growth Rate (2018-2023)
8.1.5 Japan Biosimilars Sales and Growth Rate (2018-2023)
8.1.6 Australia Biosimilars Sales and Growth Rate (2018-2023)
8.1.7 India Biosimilars Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Biosimilars Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Biosimilars Revenue (Value) by Manufacturers
8.3 Asia-pacific Biosimilars Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Biosimilars Sales Market Share by Application (2018-2023)
9 South America Biosimilars Market Size Categorized by Countries
9.1 South America Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 South America Biosimilars Sales (Volume) by Countries (2018-2023)
9.1.2 South America Biosimilars Revenue by Countries (2018-2023)
9.1.3 Brazil Biosimilars Sales and Growth Rate (2018-2023)
9.2 South America Biosimilars Sales and Market Share by Type (2018-2023)
9.3 South America Biosimilars Sales Market Share by Application (2018-2023)
10 Middle East and Africa Biosimilars Market Size Categorized by Countries
10.1 Middle East and Africa Biosimilars Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Biosimilars Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Biosimilars Revenue by Countries (2018-2023)
10.1.3 GCC Countries Biosimilars Sales and Growth Rate (2018-2023)
10.1.4 Turkey Biosimilars Sales and Growth Rate (2018-2023)
10.1.5 Egypt Biosimilars Sales and Growth Rate (2018-2023)
10.1.6 South America Biosimilars Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Biosimilars Sales and Market Share by Type
10.3 Middle East and Africa Biosimilars Sales Market Share by Application (2018-2023)
11 Global Biosimilars Market Segment by Type
11.1 Global Biosimilars Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Biosimilars Sales and Market Share by Type (2018-2023)
11.1.2 Global Biosimilars Revenue and Market Share by Type (2018-2023)
11.2 Monoclonal Antibodies Sales Growth Rate and Price
11.2.1 Global Monoclonal Antibodies Sales Growth Rate (2018-2023)
11.2.2 Global Monoclonal Antibodies Price (2018-2023)
11.3 Interferon Sales Growth Rate and Price
11.3.1 Global Interferon Sales Growth Rate (2018-2023)
11.3.2 Global Interferon Price (2018-2023)
11.4 Erythropoietin Sales Growth Rate and Price
11.4.1 Global Erythropoietin Sales Growth Rate (2018-2023)
11.4.2 Global Erythropoietin Price (2018-2023)
11.5.1 Global Insulin Sales Growth Rate (2018-2023)
11.5.2 Global Insulin Price (2018-2023)
11.6 Vaccines Sales Growth Rate and Price
11.6.1 Global Vaccines Sales Growth Rate (2018-2023)
11.6.2 Global Vaccines Price (2018-2023)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2018-2023)
11.7.2 Global Other Price (2018-2023)
12 Global Biosimilars Market Segment by Application
12.1 Global Biosimilars Sales Market Share by Application (2018-2023)
12.2 Tumor Sales Growth Rate (2018-2023)
12.3 Diabetes Sales Growth Rate (2018-2023)
12.4 Cardiovascular Sales Growth Rate (2018-2023)
12.5 Hemophilia Sales Growth Rate (2018-2023)
13 Global Biosimilars Market Forecast
13.1 Global Biosimilars Revenue, Sales and Growth Rate (2023-2028)
13.2 Biosimilars Market Forecast by Regions (2023-2028)
13.2.1 North America Biosimilars Market Forecast (2023-2028)
13.2.2 Europe Biosimilars Market Forecast (2023-2028)
13.2.3 Asia-Pacific Biosimilars Market Forecast (2023-2028)
13.2.4 South America Biosimilars Market Forecast (2023-2028)
13.2.5 Middle East & Africa Biosimilars Market Forecast (2023-2028)
13.3 Biosimilars Market Forecast by Type (2023-2028)
13.3.1 Global Biosimilars Sales Forecast by Type (2023-2028)
13.3.2 Global Biosimilars Market Share Forecast by Type (2023-2028)
13.4 Biosimilars Market Forecast by Application (2023-2028)
13.4.1 Global Biosimilars Sales Forecast by Application (2023-2028)
13.4.2 Global Biosimilars Market Share Forecast by Application (2023-2028)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Biosimilars Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Biosimilars Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Biosimilars
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilars
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilars Market Size by Type
Figure Global Market Share of Biosimilars by Type in 2022
Figure Monoclonal Antibodies Picture
Figure Interferon Picture
Figure Erythropoietin Picture
Figure Insulin Picture
Figure Vaccines Picture
Figure Other Picture
Table Global Biosimilars Market Size (Volume) by Application
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Table Global Biosimilars Comparison by Regions (M USD) 2018-2028
Figure Global Biosimilars Market Size (Million US$) (2018-2028)
Figure North America Biosimilars Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Biosimilars Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Biosimilars Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Biosimilars Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Biosimilars Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilars Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilars Sales by Manufacturer (2018-2023)
Figure Global Biosimilars Sales Market Share by Manufacturer in 2022
Table Global Biosimilars Revenue by Manufacturer (2018-2023)
Figure Global Biosimilars Revenue Market Share by Manufacturer in 2022
Table Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilars Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Biosimilars Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Biosimilars Market
Table Key Manufacturers Biosimilars Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Biosimilars Product Introduction, Application and Specification of Roche
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2018-2023
Table Roche Main Business
Table Roche Recent Development
Table Eli Lilly Company Profile
Table Biosimilars Product Introduction, Application and Specification of Eli Lilly
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2018-2023
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Sanofi-Aventis Company Profile
Table Biosimilars Product Introduction, Application and Specification of Sanofi-Aventis
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2018-2023
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Amgen Company Profile
Table Biosimilars Product Introduction, Application and Specification of Amgen
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2018-2023
Table Amgen Main Business
Table Amgen Recent Development
Table Novo Nordisk Company Profile
Table Biosimilars Product Introduction, Application and Specification of Novo Nordisk
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2018-2023
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table AbbVie Company Profile
Table Biosimilars Product Introduction, Application and Specification of AbbVie
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2018-2023
Table AbbVie Main Business
Table AbbVie Recent Development
Table Merck Company Profile
Table Biosimilars Product Introduction, Application and Specification of Merck
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2018-2023
Table Merck Main Business
Table Merck Recent Development
Table Pfizer Company Profile
Table Biosimilars Product Introduction, Application and Specification of Pfizer
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Table Johnson & Johnson Company Profile
Table Biosimilars Product Introduction, Application and Specification of Johnson & Johnson
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2018-2023
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis Company Profile
Table Biosimilars Product Introduction, Application and Specification of Novartis
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2018-2023
Table Novartis Main Business
Table Novartis Recent Development
Table Gelgen Company Profile
Table Biosimilars Product Introduction, Application and Specification of Gelgen
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen 2018-2023
Table Gelgen Main Business
Table Gelgen Recent Development
Table Ganlee Company Profile
Table Biosimilars Product Introduction, Application and Specification of Ganlee
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2018-2023
Table Ganlee Main Business
Table Ganlee Recent Development
Table 3sbio Company Profile
Table Biosimilars Product Introduction, Application and Specification of 3sbio
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2018-2023
Table 3sbio Main Business
Table 3sbio Recent Development
Table Innovent Company Profile
Table Biosimilars Product Introduction, Application and Specification of Innovent
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2018-2023
Table Innovent Main Business
Table Innovent Recent Development
Table Biotech Company Profile
Table Biosimilars Product Introduction, Application and Specification of Biotech
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biotech 2018-2023
Table Biotech Main Business
Table Biotech Recent Development
Table Changchun High Tech Company Profile
Table Biosimilars Product Introduction, Application and Specification of Changchun High Tech
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2018-2023
Table Changchun High Tech Main Business
Table Changchun High Tech Recent Development
Table Dong Bao Company Profile
Table Biosimilars Product Introduction, Application and Specification of Dong Bao
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dong Bao 2018-2023
Table Dong Bao Main Business
Table Dong Bao Recent Development
Table CP Guojian Company Profile
Table Biosimilars Product Introduction, Application and Specification of CP Guojian
Table Biosimilars Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian 2018-2023
Table CP Guojian Main Business
Table CP Guojian Recent Development
Figure Global Biosimilars Sales and Growth Rate (2018-2023)
Figure Global Biosimilars Revenue and Growth Rate (2018-2023)
Table Global Biosimilars Sales by Regions (2018-2023)
Figure Global Biosimilars Sales Market Share by Regions in 2022
Table Global Biosimilars Revenue by Regions (2018-2023)
Figure Global Biosimilars Revenue Market Share by Regions in 2022
Figure North America Biosimilars Sales and Growth Rate (2018-2023)
Figure Europe Biosimilars Sales and Growth Rate (2018-2023)
Figure Asia-pacific Biosimilars Sales and Growth Rate (2018-2023)
Figure South America Biosimilars Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Biosimilars Sales and Growth Rate (2018-2023)
Figure North America Biosimilars Revenue and Growth Rate (2018-2023)
Table North America Biosimilars Sales (Volume) by Countries (2018-2023)
Table North America Biosimilars Sales Market Share by Countries (2018-2023)
Figure North America Biosimilars Sales Market Share by Countries in 2022
Table North America Biosimilars Revenue by Countries (2018-2023)
Table North America Biosimilars Revenue Market Share by Countries (2018-2023)
Figure North America Biosimilars Revenue Market Share by Countries in 2022
Figure United States Biosimilars Sales and Growth Rate (2018-2023)
Figure Canada Biosimilars Sales and Growth Rate (2018-2023)
Figure Mexico Biosimilars Sales and Growth Rate (2018-2023)
Table North America Biosimilars Revenue by Manufacturer (2022)
Figure North America Biosimilars Revenue Market Share by Manufacturer in 2022
Table North America Biosimilars Sales by Type (2018-2023)
Table North America Biosimilars Sales Share by Type (2018-2023)
Table North America Biosimilars Sales by Application (2018-2023)
Table North America Biosimilars Sales Share by Application (2018-2023)
Figure Europe Biosimilars Revenue and Growth Rate (2018-2023)
Table Europe Biosimilars Sales (Volume) by Countries (2018-2023)
Table Europe Biosimilars Sales Market Share by Countries (2018-2023)
Figure Europe Biosimilars Sales Market Share by Countries in 2022
Table Europe Biosimilars Revenue by Countries (2018-2023)
Table Europe Biosimilars Revenue Market Share by Countries (2018-2023)
Figure Europe Biosimilars Revenue Market Share by Countries in 2022
Figure Germany Biosimilars Sales and Growth Rate (2018-2023)
Figure UK Biosimilars Sales and Growth Rate (2018-2023)
Figure France Biosimilars Sales and Growth Rate (2018-2023)
Figure Russia Biosimilars Sales and Growth Rate (2018-2023)
Figure Italy Biosimilars Sales and Growth Rate (2018-2023)
Figure Spain Biosimilars Sales and Growth Rate (2018-2023)
Table Europe Biosimilars Revenue by Manufacturer (2022)
Figure Europe Biosimilars Revenue Market Share by Manufacturer in 2022
Table Europe Biosimilars Sales by Type (2018-2023)
Table Europe Biosimilars Sales Share by Type (2018-2023)
Table Europe Biosimilars Sales by Application (2018-2023)
Table Europe Biosimilars Sales Share by Application (2018-2023)
Figure Asia-pacific Biosimilars Revenue and Growth Rate (2018-2023)
Table Asia-pacific Biosimilars Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Biosimilars Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Biosimilars Sales Market Share by Countries in 2022
Table Asia-pacific Biosimilars Revenue by Countries (2018-2023)
Table Asia-pacific Biosimilars Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Biosimilars Revenue Market Share by Countries in 2022
Figure China Biosimilars Sales and Growth Rate (2018-2023)
Figure South Korea Biosimilars Sales and Growth Rate (2018-2023)
Figure Japan Biosimilars Sales and Growth Rate (2018-2023)
Figure Australia Biosimilars Sales and Growth Rate (2018-2023)
Figure India Biosimilars Sales and Growth Rate (2018-2023)
Figure Southeast Asia Biosimilars Sales and Growth Rate (2018-2023)
Table Asia-pacific Biosimilars Revenue by Manufacturer (2022)
Figure Asia-pacific Biosimilars Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Biosimilars Sales by Type (2018-2023)
Table Asia-pacific Biosimilars Sales Share by Type (2018-2023)
Table Asia-pacific Biosimilars Sales by Application (2018-2023)
Table Asia-pacific Biosimilars Sales Share by Application (2018-2023)
Figure South America Biosimilars Revenue and Growth Rate (2018-2023)
Table South America Biosimilars Sales (Volume) by Countries (2018-2023)
Table South America Biosimilars Sales Market Share by Countries (2018-2023)
Figure South America Biosimilars Sales Market Share by Countries in 2020
Table South America Biosimilars Revenue by Countries (2018-2023)
Table South America Biosimilars Revenue Market Share by Countries (2018-2023)
Figure South America Biosimilars Revenue Market Share by Countries in 2020
Figure Brazil Biosimilars Sales and Growth Rate (2018-2023)
Table South America Biosimilars Sales by Type (2018-2023)
Table South America Biosimilars Sales Share by Type (2018-2023)
Table South America Biosimilars Revenue by Type (2018-2023)
Table South America Biosimilars Revenue Share by Type (2018-2023)
Table South America Biosimilars Sales by Application (2018-2023)
Table South America Biosimilars Sales Share by Application (2018-2023)
Figure Middle East and Africa Biosimilars Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilars Sales (Volume) by Countries (2018-2023)
Table Middle East and Africa Biosimilars Sales Market Share by Countries (2018-2023)
Figure Middle East and Africa Biosimilars Sales Market Share by Countries in 2020
Table Middle East and Africa Biosimilars Revenue by Countries (2018-2023)
Table Middle East and Africa Biosimilars Revenue Market Share by Countries (2018-2023)
Figure Middle East and Africa Biosimilars Revenue Market Share by Countries in 2020
Figure GCC Countries Biosimilars Sales and Growth Rate (2018-2023)
Figure Turkey Biosimilars Sales and Growth Rate (2018-2023)
Figure Egypt Biosimilars Sales and Growth Rate (2018-2023)
Figure South Africa Biosimilars Sales and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilars Sales by Type (2018-2023)
Table Middle East and Africa Biosimilars Sales Share by Type (2018-2023)
Table Middle East and Africa Biosimilars Revenue by Type (2018-2023)
Table Middle East and Africa Biosimilars Revenue Share by Type (2018-2023)
Table Middle East and Africa Biosimilars Sales by Application (2018-2023)
Table Middle East and Africa Biosimilars Sales Share by Application (2018-2023)
Table Global Biosimilars Sales by Type (2018-2023)
Table Global Biosimilars Sales Market Share by Type (2018-2023)
Figure Global Biosimilars Sales Market Share by Type in 2022
Table Global Biosimilars Revenue by Type (2018-2023)
Table Global Biosimilars Revenue Market Share by Type (2018-2023)
Figure Global Biosimilars Revenue Market Share by Type in 2020
Figure Global Monoclonal Antibodies Sales Growth Rate (2018-2023)
Figure Global Monoclonal Antibodies Price (2018-2023)
Figure Global Interferon Sales Growth Rate (2018-2023)
Figure Global Interferon Price (2018-2023)
Figure Global Erythropoietin Sales Growth Rate (2018-2023)
Figure Global Erythropoietin Price (2018-2023)
Figure Global Insulin Sales Growth Rate (2018-2023)
Figure Global Insulin Price (2018-2023)
Figure Global Vaccines Sales Growth Rate (2018-2023)
Figure Global Vaccines Price (2018-2023)
Figure Global Other Sales Growth Rate (2018-2023)
Figure Global Other Price (2018-2023)
Table Global Biosimilars Sales by Application (2018-2023)
Table Global Biosimilars Sales Market Share by Application (2018-2023)
Figure Global Biosimilars Sales Market Share by Application in 2022
Figure Global Tumor Sales Growth Rate (2018-2023)
Figure Global Diabetes Sales Growth Rate (2018-2023)
Figure Global Cardiovascular Sales Growth Rate (2018-2023)
Figure Global Hemophilia Sales Growth Rate (2018-2023)
Figure Global Other Sales Growth Rate (2018-2023)
Figure Global Biosimilars Sales and Growth Rate (2023-2028)
Figure Global Biosimilars Revenue and Growth Rate (2023-2028)
Table Global Biosimilars Sales Forecast by Regions (2018-2023)
Table Global Biosimilars Market Share Forecast by Regions (2018-2023)
Figure North America Sales Biosimilars Market Forecast (2023-2028)
Figure Europe Sales Biosimilars Market Forecast (2023-2028)
Figure Asia-Pacific Sales Biosimilars Market Forecast (2023-2028)
Figure South America Sales Biosimilars Market Forecast (2023-2028)
Figure Middle East & Africa Sales Biosimilars Market Forecast (2023-2028)
Table Global Biosimilars Sales Forecast by Type (2023-2028)
Table Global Biosimilars Market Share Forecast by Type (2023-2028)
Ta
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
